Uroplasty’s Neuromodulator Falls Short On Blue Cross Blue Shield Test

Evidence does not support Uroplasty’s Urgent PC neuromodulation system, a 510(k)-cleared device for treating overactive bladder and symptoms, as an effective treatment option, according to an assessment by the Blue Cross Blue Shield’s Technology Evaluation Center.

More from Archive

More from Medtech Insight